Zhinan Xia PhD

Dr. Zhinan Xia received his Ph.D. degree in Biochemistry and Molecular Biology from the University of Kentucky followed by postdoc training at Harvard Medical School in molecular immunology/oncology. He is the first scientist to express an active form of human granzyme B (T cell’s molecular knife to kill tumors and virally infected cells). Dr. Xia is currently the Founder and President of Abimmune Biotherapeutics LLC. A startup company in Kendall Sq Cambridge MA focusing on immunotherapy for devastating diseases such as cancer and immune-related rare diseases.